The challenges of conducting clinical trials in rural and remote Queensland

Clinical research in Queensland does not take place within a single health system or geography. A trial based in Brisbane may involve participants living hundreds or thousands of kilometres away, with different transport options, internet access, employment patterns, languages and expectations of care. These differences shape every stage of a study, from recruitment and consent to follow-up and the delivery of investigational treatment.

The challenges of conducting clinical trials in rural and remote Queensland are therefore practical, ethical and scientific. Research must fit the realities of communities served by small hospitals, Aboriginal and Torres Strait Islander health services, general practices and outreach teams. When trial design reflects those realities, evidence is more likely to improve care across the state rather than remain concentrated in metropolitan centres.

Distance and uneven access to services

Queensland’s size makes travel a central consideration. A participant in Mount Isa, Longreach or the Cape York Peninsula may need to travel to Townsville or Brisbane for specialist assessment, imaging or a procedure that is routine in a major metropolitan hospital. Road journeys can be long, flights may be infrequent or expensive, and wet-season conditions can disrupt access to remote communities.

The cost of participation extends beyond the research visit. People may need to take unpaid leave, arrange childcare, find accommodation or coordinate transport with family members. For older adults and people living with chronic disease, these demands can make trial participation unrealistic unless study teams provide flexible appointments, reimbursement and local options for follow-up.

Telehealth can reduce some travel, particularly for consultations and symptom monitoring. However, reliable broadband and mobile coverage are not universal, and digital appointments may not suit participants with limited data, low digital confidence or a preference for face-to-face communication.

Recruiting participants across diverse communities

Rural and remote populations are not interchangeable. A trial may involve agricultural communities near Roma, mining communities around Mount Isa, coastal populations in Cairns and culturally diverse communities across regional centres. Seasonal work, shift work, school calendars and local events can all influence whether people hear about a study and remain available.

Recruitment through trusted local clinicians is often more effective than relying on metropolitan advertising. General practitioners, Aboriginal Community Controlled Health Organisations, pharmacists and community nurses can explain the purpose of a study in familiar settings. Their involvement also helps researchers understand local concerns about privacy, travel, risk and the use of biological samples.

Engagement with Aboriginal and Torres Strait Islander communities requires time, cultural authority and clear agreements about data and specimen governance. Consent processes should be culturally safe, accessible and ongoing. Research teams need to work with community representatives from the design stage, rather than treating consultation as an administrative step after a protocol has been written.

Building capable local trial teams

Many rural hospitals and health services operate with small teams covering broad responsibilities. A nurse may combine clinical care, emergency duties and research coordination, while a regional doctor may support several specialties. Backfilling staff for training, monitoring visits or study administration can be difficult when vacancies and workforce turnover are already high.

Clinical trials also require capabilities that may not be available locally, including data entry, investigational product management, pathology processing and adverse-event reporting. Centralised support can help, but excessive reliance on Brisbane-based staff may leave local teams with extra tasks and limited ownership of the study.

Partnerships between universities, research institutes and regional health services can strengthen this capacity. The Brisbane Diamantina network provides a useful model for connecting research expertise with health services and communities, supporting translation from scientific findings into practical improvements in care.

Ethics, governance and safe data use

A study conducted across several Queensland locations may require multiple layers of review and approval. Researchers must work within the National Statement on Ethical Conduct in Human Research, Queensland Health governance requirements and relevant privacy obligations, including the Privacy Act 1988. The process can be complex when public hospitals, private practices, universities and community-controlled services are all involved.

Research governance is distinct from ethics approval. A Human Research Ethics Committee may assess consent, risk and participant welfare, while each health service must determine whether the study is feasible, properly resourced and consistent with local policy. Delays can occur when contracts, indemnity, data access and site authorisation are handled separately.

Data security is especially important when small communities are involved. Even de-identified information can become recognisable when a dataset contains a rare condition, a small population or detailed location data. Researchers should minimise unnecessary collection, explain who will access information and establish clear rules for sharing results with participating communities.

Designing trials around local life

A protocol developed for a tertiary hospital may assume frequent pathology, specialist review and immediate access to diagnostic equipment. Those assumptions can exclude rural participants or create avoidable protocol deviations. Practical alternatives might include mobile outreach clinics, local blood collection, pharmacy-based monitoring or validated home assessments.

Trial schedules should account for harvest periods, cattle work, school runs, cultural obligations and extreme weather. In many regional areas, a missed appointment is not simply an inconvenience; it may require another day of travel. Flexible visit windows and telephone follow-up can improve retention while preserving scientific quality.

Researchers also need to consider the local health market. Smaller communities may have limited private pathology services, fewer allied health providers and restricted pharmacy stock. If an investigational medicine requires cold-chain storage or frequent dose adjustments, the study must confirm that local supply and clinical support are workable before recruitment begins.

Making evidence useful after the trial

A successful trial should leave behind knowledge, skills and relationships that improve routine care. This may involve training regional clinicians, developing referral pathways, sharing plain-language results and designing implementation plans with local health services. Translation is stronger when communities can see how findings relate to their own priorities.

Funding arrangements should recognise the real cost of regional research. Budgets may need to cover travel, accommodation, freight, interpreters, community engagement, telehealth equipment and protected staff time. Competitive grants designed around metropolitan assumptions can make rural participation appear more expensive than it truly is, even when it produces more representative evidence.

Clinical research teams can monitor success through measures such as recruitment by location, participant retention, travel burden, protocol deviations and the time required to activate each site. Comparing these measures across metropolitan, regional and remote settings helps identify which barriers are structural and which can be addressed through better planning.

Queensland’s rural and remote communities should not be treated as difficult locations to add after a trial has been designed. They are essential settings for testing whether an intervention works across different circumstances, resources and populations. Researchers, health services and community partners can improve participation by planning for distance, supporting local capability and sharing responsibility for decisions.

Health research organisations seeking stronger regional studies can begin by building relationships before funding is secured, involving local services in protocol development and budgeting for the true cost of participation. With coordinated partnerships and respectful engagement, clinical trials can produce evidence that is relevant to patients and families across the whole of Queensland.